García-Gómez JI, Villaseñor Y

Language: Spanish
References: 11
Page: 87-91
PDF size: 334.97 Kb.

ABSTRACT

Background. Inflammatory breast carcinoma is the most aggressive form of breast cancer. The most frequent clinical manifestations of inflammatory breast carcinoma are inflammation, orange skin and inverted nipple. Aim. To compare clinical data with the radiological findings in patients with inflammatory breast carcinoma. Material and methods. A retrospective descriptive study was conducted including 50 patients with inflammatory data of inflammatory breast carcinoma. Results. Fifty patients were evaluated through ultrasound, mammography, tomography or MRI. The main clinical and radiological findings were similar to inflammation features and thickening of the skin. Conclusions. Radiological methods were of great help for tumor characterization, diagnosis of metastases, obtaining a tissue sample and evaluation of response to therapy.

REFERENCES

1. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, et al. International expert panel on inflammatory breast cancer; consensus statement for standardized diagnosis and treatment. Ann Oncol 2011; 22: 515-23.

2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. Ed. 7. New York: Springer; 2010.

3. Bonnier P, Charpin C, Lejeune C, Romain S, Tubiana N, Beedassy B, Martin PM, et al. Inflamatory carcinomas of the breast a clinical, pathological, or a clinical and pathological definition? Int J Cancer 1995; 62: 382-5.

4. Paradiso A, Tommasi S, Brandi M, Marzullo F, Simone G, Lorusso V, Mangia A, et al. Cell Kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease. Cancer 1989; 64: 1922-7.

5. Turpin E, Bièche I, Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Olivi M, et al. Increased incidence of ERB B2 overexpresion and TP53 mutation in inflammatory breast cancer. Oncogene 2002; 21: 7593-7.

6. Lee BJ, Tannenbaum NE. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet 1924; 39: 580-95.

7. Sanchez Basurto C. Tratado de las enfermedades de la glandular mamaria. Vol. 2. 2a Ed. Editorial Alfil; 2010, pp. 761-3.

8. Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez- Angulo AM, Dawood S, Resetkova E, et al. Inflammatory breast cancer PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008; 109: 417-26.

9. De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1978; 1: 53-9.

10. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, et al. Retrospective study of 18 FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 2009; 50: 231-8.

11. Haagensen C. Diseases of the breast. 2a Ed. Filadelfia: Pasauder; 1971: 569-84.